The Würth Group and the non-profit Würth Foundation grant EUR 50 million to promote cancer research
Over the next ten years, the Würth Group and the non-profit Würth Foundation will provide a total of EUR 50 million to fund research to combat pancreatic cancer at Champalimaud Foundation in Lisbon, Portugal.
The Champalimaud Foundation is a global research pioneer and sets new standards in knowledge to promote human health and well-being. The foundation aims at becoming a global leader in scientific and technological innovation to diagnose, treat, and control diseases. Activities at the Champalimaud Center for the Unknown (CCU) in Lisbon focus on research in the areas of neuroscience and cancer.
The funding provided by the Würth Group and the non-profit Würth Foundation aims to support research into pancreatic cancer. This type of cancer is still one of the deadliest and at the same time one of the least researched forms of cancer.
Research is led by Prof. Dr. Markus W. Büchler, a world-renowned physician in the field of pancreatic cancer research and surgery. Junior and senior physicians and scientists work together at the research center to accelerate critical breakthroughs in research and to enable physicians around the world to defeat this dangerous disease.
“We are very grateful for the support of the Würth Group and the non-profit Würth Foundation, as it facilitates many years of cancer research. This grant will help us make new progress and provide better care to patients with pancreatic cancer around the world,” said Prof. Dr. Markus W. Büchler.
About the Champalimaud Foundation
The Champalimaud Foundation was created in 2004 by the last will of the Portuguese entrepreneur António Champalimaud. The Champalimaud Foundation essentially develops research in neurosciences, cancer and vision. Their mission is to actively develop advanced research and technological innovation programs, alongside the interdisciplinary delivery of clinical care in the prevention, early diagnosis and treatment of cancer. The clinical activity is patient-centered, through the personalization of care and promotion of quality of life.
About the Würth Foundation
Back in 1987, Prof. Dr. h. c. mult. Reinhold and Carmen Würth established the Würth Foundation. As a civil law foundation based in Künzelsau, Germany, it promotes charitable and benevolent purposes. The Würth Foundation promotes a wide range of projects in the fields of art and culture, education and training, research and science, and integration. Its activities focus on the Heilbronn-Franconia region. The activities are supported by the German Würth Group companies, in particular Adolf Würth GmbH & Co. KG.
